ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PTH Promethean

3.125
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Promethean LSE:PTH London Ordinary Share GB00B08H5G38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.125 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Promethean Share Discussion Threads

Showing 101 to 125 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
05/2/2003
22:13
DR its going to happen at the AGM apparently some of the board will be removed.
Its your cash they just gave away.

ccraig69
04/2/2003
20:13
looks like more credit suisse buying today, what are they up to hmmmmm. ?
vinyy
30/1/2003
19:24
Correct me if I am wrong but the board seem to be saying that they are giving away the US IP, as what good is a minority stake in a listed (?) company, when in two years time you are hoplessly insolvent because you gave away your assets in return for shares in company listed on a plunging stockmaret.

I hope a EGM Resolutions include the removal of the board.

d r
30/1/2003
17:32
What a load of bull

egm now!!

hereshoping
30/1/2003
15:21
RNS Number:8202G
PPL Therapeutics PLC
30 January 2003

Date: Thursday 30 January 2003

Contact: Geoff Cook, Chief Executive Officer
Lindsay Dunsmuir, Chief Financial Officer
PPL Therapeutics plc
Telephone: 0131 440 4777

Alistair Mackinnon-Musson
Philip Dennis
Hudson Sandler
Telephone: 020 7796 4133
Email: ppl@hspr.co.uk



PPL Therapeutics plc

Update on status of disposal of Regenerative Medicine business

As previously announced in the company's Preliminary Results (March 2002), PPL
Therapeutics plc (PPL) has been in discussions with a number of interested
parties concerning the possible disposal of its xenograft and stem cells
programmes in the USA.

These discussions continue and PPL has today entered into an exclusive
negotiating period with US-based investors to dispose of PPL's interest in the
programmes in return for a minority equity stake in the new venture going
forward. Both parties are working together with the intention of concluding
terms for the disposal as quickly as possible.

Ends

tony14
30/1/2003
14:39
oh dear, IP`s disapearing down the plughole
overline
25/1/2003
00:27
sanghani

hope so

vinyy
25/1/2003
00:12
Credit Suisse now have ove 7% what are they upto - does any one think we are looking at stakebuilding for a bid?
sanghani
24/1/2003
11:22
CSFB - more buying now 7.09%
isis
23/1/2003
11:44
PPL Therapeutics PLC
23 January 2003

PPL Therapeutics plc ('the Company')

DISCLOSURE OF INTEREST

The Company received notification on 22 January 2003 that, following a purchase
of 450,000 shares on 20 January 2003, Credit Suisse First Boston Equities
Limited now have an interest in 7,754,110 Ordinary shares of 50p each in the
Company, representing 6.28% of the total shares in issue.


This information is provided by RNS
The company news service from the London Stock Exchange

burlington
23/1/2003
11:43
PPL Therapeutics PLC
23 January 2003

PPL Therapeutics plc ('the Company')

DISCLOSURE OF INTEREST

The Company received notification on 22 January 2003 that, following a purchase
of 450,000 shares on 20 January 2003, Credit Suisse First Boston Equities
Limited now have an interest in 7,754,110 Ordinary shares of 50p each in the
Company, representing 6.28% of the total shares in issue.


This information is provided by RNS
The company news service from the London Stock Exchange

burlington
22/1/2003
09:21
Regulatory approval for what.
Do you have a link for the story/rumour.
I thought the move up was to do with csfb actively buying stock.
TIA for any reply
Ray

raypam
22/1/2003
08:53
PPL Therapeutics - Moves up on hopes of Regulatory approval
jonny walker
21/1/2003
20:04
isis
You are right. Its big game poker.
Big players could be wondering about letting it go bust and hoping to buy bits off the receivers, or letting it be refunded, knowing they they could increase their stake where lots of private investors couldn't. It took me some time to realize that if you can afford to maintain your stake, then it doesn't matter what the share price is when refunding occurs: hence its the small guy that gets shafted by dilution and the big guy actaully can benefit by increasing his stake at low prices.

The small guy has the advantage that he can buy without moving the price, is never pressured by others to track, match or exceed an index, can take risks which you wouldn't want somebody to do with your pension, etc, so its not all to the same persons advantage.

There really is a catch 22. I have seen companies go under because the low price leads to dilution and dilution leads to low prices. When nobody has a stomach for it, including the banks, that's it, game over.

I helped out one company that had just a few days cash left. The shares are up because the danger is over, and because the danger is over, others have joined in at a higher price. If the market was not so pessismistic it could almost start a virtuous circle!

Back to PPL. The management must know that fund raising is getting harder and if they don't find cash from their own assets they could be filing receivership paperwork sometime - unless they have a dirty deal, a firm offer of finance to the detriment of the small shareholders, which they are planning to use.

I'm personally in favour of trusting the management are honest, and hoping they can sell the transpantation stuff to fund Dolly and family.

crystalclear
21/1/2003
17:15
The problem here though is if they just leave things as they are they will out of cash & need extra funding which will just keep diluting shares.
The market does'nt have much stomach for funding things which may or may not happen - so it's a catch 22. Obviously if a big player takes it over they have the access to the reserves some of these companies need.
This is a big poker game & the smaller holders are just not in it anymore.

isis
21/1/2003
17:04
That's right.
I wouldn't be suprised if teh shareholder group's existence put Bayer in a position where they felt their medicine was not in safe hands, and they may end up doing a takeover at say 10p per share instead of the medicine hitting the market and the shares being worth their real value in the future.

If there is a threat to Bayer's interests, it is natural that they defend themselves.

Probably wrong, but just wondering if the pressure group will end up having done great harm to its own shareholders. I am holding shares at about 7p, but I'd much prefer they got back to 50p offer price than the group forced Bayer to accumulate a 30% stake and then offer a 30% premium to the current price as part of a takeover.

crystalclear
21/1/2003
16:30
Just watching a program on Discovery Sci-Trek which is about Gene-Cloning & how huge it may become.
Includes a PPL pig & cow & says the cow is worth over a million pounds. Bayer can pick up this company for virtually its NAV - so perhaps it's on it's way!

isis
21/1/2003
15:39
I see from Paulypilot site that CSFB helped Bayer with a large acquisition in the past. Therefore interesting to speculate whether they are now stake building for Bayer.
This COULD all be resolved faster than expected.

james8
20/1/2003
16:02
Nice one. :)
isis
20/1/2003
15:54
PPL Therapeutics PLC
20 January 2003

PPL Therapeutics plc ('the Company')

DISCLOSURE OF INTEREST

The Company received notification on 17 January 2002 that, following a purchase
of 1,250,000 shares on 16 January 2003, Credit Suisse First Boston Equities
Limited now have an interest in 6,304,110 Ordinary shares of 50p each in the
Company, representing 5.10% of the total shares in issue.


This information is provided by RNS
The company news service from the London Stock Exchange

burlington
20/1/2003
15:40
It's your investment portfolio and hard earned money. So, everything and everyone has to do more than expected. This premium online newsletter is made for people like you. It's designed to do everything you need and then some, with an amazing track record and experience. You just found the right one.
latifahq
20/1/2003
15:39
this is looking good
chask
19/1/2003
18:10
update of action gp intentions:-
james8
19/1/2003
00:36
Hey thinkBIG.

What happened to your ramping over at IFX? I've not heard much from you or your mate lately.

Jacko

jacko 1972
18/1/2003
11:03
some big buys any one know why?
thinkbig?
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older

Your Recent History

Delayed Upgrade Clock